.jpg?format=webp&width=780)
Obesity increases both the incidence and the severity of asthma. Obese asthmatics experience more frequent exacerbations and often respond poorly to currently available asthma medications, increasing healthcare costs and decreasing quality of life. Prevention and management of this challenging disease are complicated by the lack of a complete understanding of its underlying molecular mechanisms. Furthermore, increased bronchoconstriction is independent of airway inflammation in obese animals. The existing inflammatory paradigms, which have produced significant therapeutic advances for other phenotypes and endotypes of asthma, require reexamination in the context of an obesity-related phenotype.
Like
Save
Share